CYMABAY THERAPEUTICS INC's ticker is and the CUSIP is 23257D953. A total of 3 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,996 | +199500.0% | 133,900 | +133800.0% | 0.00% | – |
| Q2 2023 | $1 | -99.7% | 100 | -99.7% | 0.00% | – |
| Q1 2023 | $347 | +265.3% | 39,900 | +162.5% | 0.00% | – |
| Q4 2022 | $95 | -99.9% | 15,200 | -33.9% | 0.00% | – |
| Q3 2022 | $80,000 | +17.6% | 23,000 | -0.4% | 0.00% | – |
| Q2 2022 | $68,000 | +33.3% | 23,100 | +39.2% | 0.00% | – |
| Q1 2022 | $51,000 | +218.8% | 16,600 | +232.0% | 0.00% | – |
| Q4 2021 | $16,000 | -83.2% | 5,000 | -76.9% | 0.00% | – |
| Q3 2021 | $95,000 | +14.5% | 21,600 | +13.1% | 0.00% | – |
| Q2 2021 | $83,000 | +130.6% | 19,100 | +23480.2% | 0.00% | – |
| Q1 2021 | $36,000 | – | 81 | +350.0% | 0.00% | – |
| Q4 2020 | $0 | – | 18 | -76.6% | 0.00% | – |
| Q3 2020 | $0 | – | 77 | -33.6% | 0.00% | – |
| Q2 2020 | $0 | – | 116 | +5700.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 2 | -93.9% | 0.00% | – |
| Q3 2019 | $16,000 | -87.5% | 33 | -81.7% | 0.00% | – |
| Q2 2019 | $128,000 | +14.3% | 180 | +111.8% | 0.00% | – |
| Q1 2019 | $112,000 | +60.0% | 85 | -4.5% | 0.00% | – |
| Q4 2018 | $70,000 | -48.1% | 89 | -27.0% | 0.00% | – |
| Q3 2018 | $135,000 | +13400.0% | 122 | +12100.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,200 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 23,000 | $80,000 | 0.00% |